Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. - Wikidata - wikimedia - TriplyDB

Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.

Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.

http://www.wikidata.org/entity/Q48495331

about

Brain resuscitation in the drowning victim Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Erythropoietin for preterm infants with hypoxic ischaemic encephalopathy Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic-Ischemic Encephalopathy Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy - Where to from Here?Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990.Neonatal-perinatal medicine in a transitional period in China Growth factors for the treatment of ischemic brain injury (growth factor treatment)Erythropoietin and Neonatal Neuroprotection Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents.Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges.Outcomes of extremely low birth weight infants given early high-dose erythropoietin.Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.The effect of erythropoietin on the severity of retinopathy of prematurity Synergistic neuroprotective therapies with hypothermia.Hypothermia for hypoxic-ischemic encephalopathy.Hypoxic ischemic brain injury: Potential therapeutic interventions for the future.General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.Developmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: do data justify changing clinical practice?Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia.Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Neurotrophin-induced migration and neuronal differentiation of multipotent astrocytic stem cells in vitro.Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury New antioxidant drugs for neonatal brain injury.The biological basis of injury and neuroprotection in the fetal and neonatal brain.Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments.Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells.Current controversies in newer therapies to treat birth asphyxia Erythropoietin: still on the neuroprotection road Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.

P2860

Q23909719-414D5DD3-1F16-4ADD-8291-92FCCEFEFEC7 Q24195000-5D9DF205-B4B4-4D73-A4D9-D275BDC1770E Q24200642-69280F14-D50D-4AB5-86A4-F25263369B41 Q24202635-F22F9801-0F70-4A24-9CE6-D78D62A7C42E Q24245418-8C243556-C6F9-420E-9430-E90F1218F597 Q26768557-C4855CFE-5DD2-45D0-A140-C28ECF37E3F6 Q26781465-1C28B5D7-E24E-4FD0-872D-58C35A1C5F8D Q26782756-7716CD81-DA2A-4135-978C-98F3ED134ED9 Q27000167-F1B60069-9E82-4DCB-B7B1-F71F2A6946EC Q27001259-420F236E-5231-4800-9B52-5F0A2C6D0C3D Q27005953-A367CE27-0361-4CF4-A5A0-DE7D4DF38ACC Q27009422-B7D37318-B404-4CB8-9C01-6567AA75A70D Q28083718-4A2259CF-68EA-4379-9610-E9CEB5D2D751 Q30444534-B9B391A0-72DB-403C-8608-6F137F9AD049 Q30847961-B6287E3C-5973-478C-90CD-7B2C19981405 Q33642422-41E8B5C2-B2D8-4020-9FCD-3B4573569432 Q33723452-9EE1A9F6-C079-4A7B-A069-3F57AE0E96AD Q33768231-6481166A-26ED-4B62-8D77-3A5958314208 Q33812116-266B7245-6310-4F70-B49E-6DB95A97413F Q33891194-FE424815-8B3D-40F0-A566-12E2950F623F Q33943360-5D998557-FF8F-401C-A8BE-00C9D7C80672 Q33961885-2A732940-411E-41B9-9FF7-AFADBE2B1004 Q34106605-21E6540C-34E7-47A5-87D1-1193E8993035 Q34117531-A3F626AC-626B-460D-89B7-48EF1B776435 Q34124787-26A3AA9D-4D09-4081-85B5-AB025F6F7152 Q34166139-9D558B00-F732-45B4-A3D0-3310CA7ED012 Q34235166-5BD5B13C-1189-4147-A65D-0CF7F11F38AD Q34504572-F016BB13-906D-4BE2-9F07-D5C5A49FA5E3 Q34517108-647AC2AF-0081-4FAD-BF9A-7E3F5A3F4CA8 Q34546517-108AC1AE-FD4A-4E23-BAED-DE9D4C15FBF1 Q34829252-7EE3E02C-5BDB-4BBC-BC6B-B48F03948DD5 Q35037632-EA814F96-AA4F-4CF5-BDB8-C7020D37E4B3 Q35201430-3E0A41C0-03B9-400C-B7B2-790684C589A0 Q35202607-F4FB0171-4592-4734-8D48-0A84B907B29A Q35209809-5F21D65D-A3F8-4029-A9C6-23AF34EB6703 Q35471285-DDEB2FD9-3B0E-4AC8-BB90-45A8A73618FC Q35524174-4265D4BA-A60A-4156-BE46-91D4B7C24E3E Q35585490-08DE32AA-45C7-4BBA-90B5-1C6B358CF07E Q35949322-6133585F-2731-45FD-AA7E-D22B4E37BDBB Q36277628-BD26ABE7-7A02-4AB3-87D0-21F507FCD808

P2860

Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.

http://www.wikidata.org/entity/Q48495331

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@en

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@nl

type

label

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@en

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@nl

prefLabel

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@en

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@nl

P1433

Q48495331-D81BA913-310F-4F8B-B151-D8D9B947CCC2

P1476

Q48495331-890C3B2D-4EAB-43D7-88B0-5FB18BBFD208

P2093

Q48495331-3189C9E4-B8F6-4239-9AC6-F76D40C925F8

Q48495331-36D35B7E-E438-4727-B3E1-0C113BE6EAD0

Q48495331-54F19848-E679-4BB7-B194-D713A2CD9391

Q48495331-7BCF8652-8749-4819-BE2D-18D2EFB6B9DC

Q48495331-8A942B1B-9EFD-49E1-8C3F-01E2B2A3AB31

Q48495331-8AF34BF8-570C-4BD8-884E-0F9A767657FC

Q48495331-96A3ECA1-4ADE-44F1-B399-A7BBE45DF455

Q48495331-C28278B0-2796-4044-A943-7415C0964C6C

Q48495331-E864A463-872C-4651-815A-FC0F4B6378E5

Q48495331-F6E6A962-E7BF-436B-A0E0-A5791EA2A76A

P304

Q48495331-1AC35AAA-2C3A-4A07-8DC1-7964329FD549

P31

Q48495331-1FB145EC-509F-41F4-8E5E-47A90058278D

P356

Q48495331-058B2781-07EE-4411-B980-1C627E481A83

P407

Q48495331-349868DB-9239-4D5B-8DCE-C5D9AEF0873B

P433

Q48495331-7A5EB906-626F-4B03-B1FA-57826D5F413D

P478

Q48495331-8A008522-AA21-4BB2-83F1-6E70CF0DC538

P50

Q48495331-02F90671-FCBB-4989-BA74-3B8A5BF072D2

Q48495331-EB341985-C198-405A-A921-914EA1DFC763

P577

Q48495331-FFC6AEEC-39EF-40F9-BF75-CBB2B0B645F8

P5875

Q48495331-914BF457-233E-4E5C-A3C7-F2CCFEDF6E7C

P698

Q48495331-45ECF667-E101-4F03-8103-D3B88DC18AFF

P921

Q48495331-0D745930-391D-412E-BBCC-08660D823EC0

Q48495331-E97115DD-BA71-4602-9365-F4E2EE6649F0

P356

P1433

P1476

Erythropoietin improved neurol ...... poxic-ischemic encephalopathy.

@en

P2093

Changlian Zhu

http://www.w3.org/2001/XMLSchema#string

Falin Xu

http://www.w3.org/2001/XMLSchema#string

George Simbruner

http://www.w3.org/2001/XMLSchema#string

Hong Xiong

http://www.w3.org/2001/XMLSchema#string

Ling Ji

http://www.w3.org/2001/XMLSchema#string

Liting Jia

http://www.w3.org/2001/XMLSchema#string

Wenqing Kang

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Guo

http://www.w3.org/2001/XMLSchema#string

Xiuyong Cheng

http://www.w3.org/2001/XMLSchema#string

Zhan Zhang

http://www.w3.org/2001/XMLSchema#string

P304

e218-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2008-3553

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26713857

http://www.w3.org/2001/XMLSchema#string

P698

19651565

http://www.w3.org/2001/XMLSchema#string

P921